MedPath

The effect of a decision aid for prenatal testing of fetal abnormalities compared to a pamphlet on improving women’s informed choice and decreasing decisional conflict: a randomised controlled trial.

Active, not recruiting
Conditions
Women's decision-making regarding prenatal genetic tests.
Reproductive Health and Childbirth - Antenatal care
Registration Number
ACTRN12606000234516
Lead Sponsor
Jane Halliday, Murdoch Childrens Research Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Active, not recruiting
Sex
Female
Target Recruitment
664
Inclusion Criteria

Victorian GPs will be eligible for participation provided they consult with least 30 women meeting the selection criteria in a 12-month period. Pregnant attending a participating GP will be eligible if they are: less than 12 weeks gestation.

Exclusion Criteria

1. are non-english speaking2. are unable to give written informed consent3. require genetic counselling due to a familiy history of an inherited disorder4. have not undertaken any testing to date for fetal abnormality in this pregnancy5. are currently experiencing vaginal bleeding6. have a known multiple pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Informed choice and decisional conflict[Measured at 14 weeks gestation]
Secondary Outcome Measures
NameTimeMethod
Acceptability of the decision aid/pamphlet to women and GPs.[Measured at 14 weeks];Anxiety, Depression, attitudes to the pregnancy/fetus.[Measured at 14 weeks, 24 weeks and 3 months post partum.];Satisfaction with the decision, and decisional regret.[Measured at 24 weeks and 3 months post partum.];Changes in informed choice and decisional conflict.[Measured at 24 weeks and 3 months post partum.]
© Copyright 2025. All Rights Reserved by MedPath